Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Datasets
Press/Media
Activities
Fellowships, Honors, and Prizes
Impacts
Search by expertise, name or affiliation
Lessons from the Established Status Epilepticus Treatment Trial
Hannah R. Cock
,
Lisa D. Coles
, Jordan Elm
, Robert Silbergleit
, James M. Chamberlain
,
James C. Cloyd
, Nathan Fountain
, Shlomo Shinnar
, Dan Lowenstein
, Robin Conwit
, Thomas P. Bleck
, Jaideep Kapur
Experimental and Clinical Pharmacology
Research output
:
Contribution to journal
›
Article
›
peer-review
14
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Lessons from the Established Status Epilepticus Treatment Trial'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Treatment Trials
100%
Status Epilepticus Treatment
100%
Established Status Epilepticus
100%
Trial Design
50%
New-onset Refractory Status Epilepticus (NORSE)
50%
Seizure
25%
Levetiracetam
25%
Quality Assurance
25%
Lessons Learned
25%
Comparative Effectiveness Studies
25%
Clinical Practice
25%
Pediatric Population
25%
Benzodiazepines
25%
Practical Implementation
25%
Design Implementation
25%
All Ages
25%
Adult Population
25%
Treatment Goals
25%
Ethical Considerations
25%
Valproate
25%
Emergency Setting
25%
Fosphenytoin
25%
Emergency Condition
25%
Pharmacology, Toxicology and Pharmaceutical Science
Epileptic State
100%
Benzodiazepine
16%
Effectiveness Study
16%
Sodium Valproate
16%
Fosphenytoin Sodium
16%
Levetiracetam
16%